University of Wisconsin–Madison Medical College of Wisconsin

Massive Rectal Bleeding After Rubber Band Ligation of Internal Hemorrhoids: A Case Report

Andrew M. Turunen, MD; Sushil Kumar Garg, MBBS; Talya A. Lorenz, MD

WMJ. 2025;124(4):378-380.

Download full-text pdf.

ABSTRACT

Introduction: Rubber band ligation (RBL) is a common treatment for internal hemorrhoids. Although generally safe, complications such as delayed bleeding can occur, particularly in patients taking anticoagulants, antiplatelets, or nonsteroidal anti-inflammatory drugs (NSAIDs).

Case Presentation: A 34-year-old White woman presented with massive rectal bleeding 15 days after suction RBL of internal hemorrhoids. She was not taking anticoagulants, antiplatelets, or NSAIDs and had no history of bleeding disorders. Flexible sigmoidoscopy revealed a 10-mm ulcer with a visible vessel at the previous banding site. Hemostasis was achieved with clip placement and hemostatic spray. She recovered without further complications.

Discussion: Massive bleeding following RBL is rare, especially in patients without traditional bleeding risk factors. Literature review identified only one similar case. Most reported cases involve patients on aspirin or other blood-thinning agents. This case adds to the limited data on severe post-RBL bleeding in low-risk individuals and highlights the potential for delayed presentation.

Conclusions: This case highlights the potential for delayed and significant bleeding post-RBL, even in patients without traditional bleeding risk factors. Vigilance beyond the immediate postoperative period is essential, and patients should be counseled on signs of delayed complications.


Author affiliations: Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin (Turunen); Division of Gastroenterology, Mayo Clinic Health System, Eau Claire, Wisconsin (Garg); Department of Surgery, Mayo Clinic Health System, Eau Claire, Wisconsin (Lorenz).
Corresponding author:
Andrew M. Turunen, MD, email ATurunen@uwhealth.org; ORCID ID 0009-0001-0416-6660
Financial disclosures: None declared.
Funding/support: None declared.
Informed consent: Informed patient consent was obtained for publication of case details.
Share WMJ